Private Equity

In a recent article in Becker's ASC Review, private equity was listed as one of three disruptors in the ASC Space, the other two being supply costs and staffing shortages. 

As private equity's influence in healthcare increases, many leaders are concerned about how it will affect physicians and ASCs. 

Here are five private equity powerhouses ASC leaders should know: 

Elgin, Ill.-based DxTx Pain and Spine has secured a $50 million private equity investment from international firm BC Partners Credit. 

Orthopedics has a unique position within the healthcare ecosystem as a highly fragmented industry ripe with potential for standardization and value-based care. There is a strong demand for affiliation with orthopedic groups, according to a new report from VMG Health,…

Private equity firms spent $206 billion on 1,400 healthcare acquisitions in 2021, according to a report by AMN Healthcare. 

As private equity becomes more prevalent in healthcare, physicians have divided opinions on its importance and its use. 

Here are five private equity-backed ASC-focused companies making waves in the surgery center space: 

As private equity increasingly invests in ASCs and physician groups, some leaders are concerned about its effect on patient outcomes and costs. 

Here are six notes about private equity's ASC influence from the last year: